Salesforce has made a strategic investment in the HR software developer, which has increased its total funding to $35m.
Month: January 2021
Telus Ventures leads $23m AgriWebb series B
Telus Ventures has led a series B round for the farm management software company, which has valued it at more than $78m.
Liran lures series B funding
Susquehanna International Group and Hupu returned to back a $23.2m round for the men’s grooming brand after previously supplying it with capital in 2020.
Make Essense makes up series B round
SIG and Hupu have returned to take part in a $23.2m round for the men’s cosmetics provider, having respectively backed its series A and A-plus rounds last year.
Vectorized elects to reveal funding
GV has participated in a $12.5m series A round for the data streaming platform provider disclosed alongside $3m in seed funding.
Elinvar covets fresh funding
FinLeap and Talanx Ampega have returned to back a $30.4m round for their joint venture, which helps wealth managers digitalise business processes.
Quantifind uncovers $22m
S&P Global and Snowflake have invested in a round that boosted the financial risk management software provider’s overall funding to more than $74m.
Corporate venturing deal net: 18-22 January 2021
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mercado Bitcoin bags funding
Banco Plural took part in a $37.2m round for the digital currency exchange that will support its international expansion.
NEA launches Global Innovation Venturing
Claudia Fan Munce, former head of IBM Ventures and now senior adviser to venture capital firm NEA as well as a board director of public companies, reflected in her keynote before yesterday’s GCV Rising Stars and Emerging Leaders Awards on how far the corporate venturing community has come over the past decade and opportunities that lie ahead in partnership with other investors.
Boston Scientific takes care of $925m Preventice acquisition
The medical equipment maker is set to pay as much as $925m to buy its portfolio company that will enable Novo, Merck & Co and Samsung to exit.
4Paradigm charts $700m series D
China Three Gorges, Cisco and Lenovo-backed 4Paradigm has closed a $700m series D round after more than a dozen backers threw their weight behind the enterprise AI developer.
TripActions books $155m series E
Lufthansa’s portfolio company TripActions has attracted $155m in series E financing co-led by Andreessen Horowitz, Addition and Elad Gil at a valuation of $5bn.
Decipher Biosciences to penetrate public markets
UnitedHealth Group and Merck & Co are both in line for exits as Decipher Biosciences files for a $100m initial public offering.